In another study, which was not included in this meta-analysis due to missing data, PAI-1 levels were significantly decreased after six months of use of 35 μg EE and 2 mg CPA by PCOS patients (ES = -0.7 IU/ml, p = 0.004) [17]. Here, SERPINE1 is linked to polycystic ovary syndrome.